INS and type 2 diabetes mellitus: Therefore, this study is aimed at elucidating the effects of a GLP-1RA on the metabolic characteristics, body fat distribution, and CVD risk factors in a final cohort of 81 normal BMI Chinese patients with T2DM and visceral adiposity who completed a 24-week intervention that compared the effects of exenatide (a GLP-1RA) and humalog Mix25 (synthetic insulin).